Profound Medical Corp.
For the period ended Sep 30, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 13, 2025
PROF$7.68+4.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets (Unaudited)
CONDENSED CONSOLIDATED BALANCE SHEET****S
| | | | | |
|---|---|---|---|---|
| | | September 30, | | December 31, |
| | 2025 | 2024 | ||
| | | $ | | $ |
| Assets | | | | |
| | | | | |
| Current assets: | | | | |
| Cash | | 24,826 | 54,912 | |
| Trade and other receivables, net (note 3) | | 8,166 | 7,045 | |
| Inventory (note 4) | | 8,337 | 5,801 | |
| Prepaid expenses and deposits | | 195 | 1,307 | |
| Total current assets | | 41,524 | 69,065 | |
| | | | | |
| Property and equipment, net (note 5) | | 338 | 425 | |
| Intangible assets, net (note 6) | | 123 | 261 | |
| Right-of-use assets, net | | 240 | 396 | |
| Deferred tax assets, net | | 80 | | 87 |
| Total assets | | 42,305 | 70,234 | |
| | | | | |
| Liabilities | | | | |
| | | | | |
| Current liabilities: | | | | |
| Accounts payable | | 717 | 1,317 | |
| Accrued expenses and other current liabilities (note 7) | | 3,972 | 2,835 | |
| Deferred revenue | | 434 | 419 | |
| Long-term debt (note 8) | | 4,480 | 1,737 | |
| Lease liabilities | | 277 | 257 | |
| Income tax payable | | 58 | — | |
| Total current liabilities | | 9,938 | 6,565 | |
| | | | | |
| Deferred revenue | | 148 | 49 | |
| Long-term debt (note 8) | | — | 2,924 | |
| Lease liabilities | | — | 203 | |
| Other non-current liabilities | | 76 | 71 | |
| Total liabilities | | 10,162 | 9,812 | |
| | | | | |
| Shareholders’ equity | | | | |
| | | | | |
| Common shares, no par value, unlimited shares authorized, 30,193,592 and 30,039,809 issued and outstanding at September 30, 2025 and December 31, 2024, respectively (note 9) | | 282,751 | 281,552 | |
| Additional paid-in capital | | 24,208 | 21,298 | |
| Accumulated other comprehensive income | | 4,750 | 2,742 | |
| Accumulated deficit | | (279,566) | (245,170) | |
| Total shareholders’ equity | | 32,143 | 60,422 | |
| | | | | |
| Total liabilities and shareholders’ equity | | 42,305 | 70,234 | |
Going Concern (note 1)**
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.